Last reviewed · How we verify

NCT06228469

Cytolytic Vaginosis Multicentre Registry

Completed Last updated 14 April 2026
What this trial tests

trial in Cytolytic Vaginosis in 32 participants. Completed in 31 December 2025.

Timeline
1 March 2024
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorUniversity of Alberta
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date1 March 2024
Primary completion31 December 2025
Estimated completion31 December 2025
Sites3 locations across Portugal, Canada, Brazil

Conditions studied

Sponsor

University of Alberta

Who can join

18 and older, female only, with Cytolytic Vaginosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this registry is to learn more about cytolytic vaginosis, a little known and controversial condition. The main questions the registry aims to answer are: * What are risk factors of cytolytic vaginosis? * Are there defining symptoms of cytolytic vaginosis? * What features on wet mount should be used to diagnosis cytolytic vaginosis? * Are baking soda vaginal irrigations an effective treatment for cytolytic vaginosis? * Do characteristics of cytolytic vaginosis vary between sites/countries?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Alberta trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06228469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing